Obido, Al-nadjer .

HRN: 27-43-22  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/07/2026
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
04/07/2026
04/14/2026
PO
2.5mL
BID
PCAP;UTI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary TractPneumonia    Compliance to guidelines: Compliant To Guidelines